HeartSafe Mammography

One Mammogram. Two Life-Saving Insights

Powered by cmAngio®

 

Envision a world where a single mammogram not only screens for breast health but also offers critical insights into cardiovascular well‑being.

Rezolut proudly introduces HeartSafe Mammography. Now, your annual screening delivers both breast cancer detection and evaluation of cardiovascular signals, like breast arterial calcifications (BAC), in a single visit, with no extra radiation or appointments.

Heart disease and breast cancer remains a leading cause of mortality among women, with1 in 5 women succumbing to this condition. Despite being a prevalent threat, heart disease can often manifest insidiously, making early detection challenging. Alarmingly, 64% of women who tragically lose their lives to heart disease exhibit no symptoms or have their warning signs overlooked.

 

What Is HeartSafe Mammography?

A Smarter Screening in One Visit

By harnessing cutting-edge artificial intelligence technology, radiologists can pinpoint and measure the presence of Breast Arterial Calcifications (BAC) during your routine mammogram, enabling them to gauge your risk of heart disease directly through this imaging procedure, all with no additional scans, no extra time, and no added exposure.

Photo of a woman receiving a mammogram
 
 

  • No extra imaging

  • No extra time

  • No additional radiation

  • BAC detection powered by FDA-cleared AI

 

Why BAC Matters

More Insight = Better Care

While BAC often appears harmless on mammograms, research suggests it can indicate broader vascular changes. If BAC is detected, your provider may recommend follow‑up with a cardiologist or primary care provider to assess cardiovascular risk.

  • 1 in 5 women die from heart disease

  • 12-42% of mammograms reveal the presence of vascular calcification

  • 64% of women who die from heart disease are asymptomatic

  • Patients with BAC are 3.5X more likely to have cardiovascular disease

 

Routine Health Screenings

Taking Care of Your Well-being

Regular health screenings are an essential part of maintaining good health for yourself and your loved ones. By staying up to date with screenings for conditions such as heart disease, cancer, diabetes, and more, you can catch potential issues early and take proactive steps toward treatment and prevention. Your well-being is worth the investment in preventive care.

Take Charge of Your Breast & Heart Health

Book your HeartSafe Mammogram at a Rezolut Imaging Center today for comprehensive health insights in a single visit.

 

HeartSafe Mammography is available at the following Rezolut Imaging Centers:

  • Center 1

  • Center 2

  • Center 3

  • Center 4

  • Center 5

  • Center 6

 

FAQs

  • cmAngio® is an FDA-cleared AI tool that identifies the presence or absence of BAC on screening mammograms and highlights it for your radiologist to review.

  • No additional radiation is used. Your regular mammogram is analyzed, there’s no need for another scan.

  • Not at all. BAC analysis is done at the same time as your standard mammogram review.

  • It’s considered a benign finding, but you may be advised to follow up with your physician to evaluate your overall health and potential cardiovascular risks.

  • TBD

  • Yes. cmAngio® can be applied to past mammograms if you choose to opt in after your appointment.

  • Not currently. However, you may use HSA or FSA funds to pay the out-of-pocket fee.

  • TBD

  • Visit www.CureMetrix.com for scientific studies and technical information.

 

HeartSafe Mammography uses cmAngio®, an FDA-Cleared Artificial Intelligence (AI) based detection software, to identify the presence or absence of breast arterial calcification (BAC) as an incidental finding in FFDM and DBT screening mammograms. The finding indicates whether calcium buildup is present in the breast arterial wall. BAC has been associated with a higher risk of coronary heart or cardiovascular disease, but the presence or absence of BAC alone is not a diagnosis for coronary heart or cardiovascular disease or determinative of a patient’s risk for coronary heart or cardiovascular disease. Results may be used for further patient management at the discretion of a primary care physician, cardiologist, or specialist. If BAC is detected, please consult your primary care physician, a cardiologist, or specialist for further information on diagnosis and treatment. FDA 510(k) Submission #K232367.